STAT

At White House opioid commission meeting, insurance industry gets a scolding

The meeting underlined members' concern that the insurance industry needs to take stronger action to help address the nation’s opioid crisis.
Patrick Kennedy, a member of the president's opioid commission, said insurers "have treated mental health and addiction as if it’s something other than the rest of medicine."

WASHINGTON — Patrick Kennedy, it seemed, had been waiting for a public opportunity to speak directly to the nation’s health insurers.

“The historic treatment of addiction and mental illness has been a separate and unequal process,” the former Rhode Island congressman and a member of the president’s opioid commission told a group of insurance executives on Friday. “All of you, as insurers and payers, have treated mental health and addiction as if it’s something other than the rest of medicine.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A 486% Drug Price Hike, AstraZeneca CEO Pay, And More
Is there any circumstance when a 486% increase for a medicine might be justified? A small company called Harrow argues the case for an injectable eye treatment.
STAT1 min read
Disparities In Donor Acceptance Rates Point To Need For More Equitable Heart Transplant Care
While access to donor hearts has increased, there are still gender- and race-based disparities in the acceptance rate of a donor heart offer by transplant teams, a new study finds.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.

Related Books & Audiobooks